PerkinElmer Inc. (NYSE:PKI) made announcements on two software firm acquisition deals intended to expand its offerings for the pharmaceutical industry.
The Waltham, Mass.-based life science and health IT firm said it will spend about $220 million as it closed its deal on R&D software company ArtusLabs Inc. and announced an agreement to acquire CambridgeSoft Corp.